![Mark Mossler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Mossler
Plus aucun poste en cours
Fortune : 79 551 $ au 31/05/2026
Profil
Mark Mossler worked as Senior Director-Global Accounting at BeOne Medicines Ltd. from 2017 to 2023.
Mr. Mossler worked as Chief Accounting Officer at C4 Therapeutics, Inc. from 2023 to 2026.
Mr. Mossler completed undergraduate and MBA degrees at Babson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/02/2026 | 18 204 ( 0,02% ) | 79 551 $ | 31/05/2026 |
Anciens postes connus de Mark Mossler
| Sociétés | Poste | Fin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15/05/2026 |
| BEIGENE LTD | Comptroller/Controller/Auditor | 01/06/2023 |
Formation de Mark Mossler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
